Vertex Pharmaceuticals (Canada) Incorporated
Vertex Pharmaceuticals (Canada) Incorporated has met with MPs 7 times since January 2024, reaching 7 MPs across 2 parties. Most recent contact: June 4, 2026.
What they're asking for
In the registry's own words. Descriptions are only filed for meetings since mid-2024.
Bill S-201, National Framework on Sickle Cell Disease Act, respecting provisions outlined in Section 2, subsections (a), (b), (e), and (i).
June 4, 2026 · Juanita Nathan · Liberal · Health; Budget; Economic Development; Federal-Provincial Relations
Engagement on issues related to access to medicines, National Pharmacare, and a National Strategy for Drugs for Rare Diseases.
March 24, 2026 · Dan Mazier · Conservative · Health; Budget; Economic Development; Federal-Provincial Relations
Innovation, Science and Economic Development Canada Innovation and Skills Strategy and other government policies and programs related to incentivizing research and development activities in Canada.
March 10, 2026 · Tom Kmiec · Conservative · Health; Intellectual Property; Budget; Economic Development; Federal-Provincial Relations
Full meeting log
7 MP-directed communications since January 2024, from the Registry of Lobbyists.
| Date | MP |
|---|---|
| 2026-06-04 | Juanita Nathan · Liberal |
| 2026-03-24 | Dan Mazier · Conservative |
| 2026-03-16 | Parm Bains · Liberal |
| 2026-03-10 | Tom Kmiec · Conservative |
| 2026-03-10 | Salma Zahid · Liberal |
| 2026-03-09 | Judy A. Sgro · Liberal |
| 2025-11-19 | Michael Coteau · Liberal |